Advertisement

Parkinson's Disease and Sleepiness

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rye D.
        • Iranzo A.
        The nocturnal manifestations of waking movement disorders: focus on Parkinson's disease.
        in: Guilleminault C. Handbook of clinical neurophysiology, vol. 6. Sleep and its disorders. Elsevier, Philadelphia2005: 263-272
        • Nausieda P.A.
        Sleep in Parkinson's disease.
        in: Koller W.C. Handbook of Parkinson's disease. 2nd edition. Marcel Dekker, New York1992: 451-467
        • Frucht S.
        • Rogers M.D.
        • Greene P.E.
        • et al.
        Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.
        Neurology. 1999; 52: 1908-1910
        • Olanow C.W.
        • Schapira A.H.V.
        • Roth T.
        Waking up to sleep episodes in Parkinson's disease.
        Mov Disord. 2000; 15: 212-215
        • Frucht S.J.
        • Greene P.E.
        • Fahn S.
        Sleep episodes in Parkinson's disease: a wake-up call.
        Mov Disord. 2000; 15: 601-603
        • Tandberg E.
        • Larsen J.P.
        • Karlsen K.
        Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study.
        Mov Disord. 1999; 14: 922-927
        • Tan E.K.
        • Lum S.Y.
        • Fook-Chong S.M.C.
        • et al.
        Evaluation of somnolence in Parkinson's disease: comparison with age and sex-matched controls.
        Neurology. 2002; 58: 465-468
        • Hobson D.E.
        • Lang A.E.
        • Martin W.W.R.
        • et al.
        Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian movement disorder group.
        JAMA. 2002; 287: 455-463
        • Kumar S.
        • Bhatia M.
        • Behari M.
        Sleep disorders in Parkinson's disease.
        Mov Disord. 2002; 17: 775-781
        • Fabbrini G.
        • Barbanti P.
        • Aurilia C.
        • et al.
        Excessive daytime sleepiness in de novo and treated Parkinson's disease.
        Mov Disord. 2002; 17: 1026-1030
        • O'Suilleabhain P.E.
        • Dewey R.B.
        Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease.
        Arch Neurol. 2002; 59: 986-989
        • Högl B.
        • Seppi K.
        • Brandauer E.
        • et al.
        Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.
        Mov Disord. 2003; 18: 319-323
        • Brodsky M.A.
        • Godbold J.
        • Roth T.
        • et al.
        Sleepiness in Parkinson's disease: a controlled study.
        Mov Disord. 2003; 18: 668-672
        • Kumar S.
        • Bhatia M.
        • Behari M.
        Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS).
        Sleep Med. 2003; 4: 339-342
        • Furumoto H.
        Excessive daytime somnolence in Japanese patients with Parkinson's disease.
        Eur J Neurol. 2004; 11: 535-540
        • Arnulf I.
        Excessive daytime sleepiness in parkinsonism.
        Sleep Med Rev. 2005; 9: 180-200
        • Meindorfner C.
        • Körner Y.
        • Möller J.C.
        • et al.
        Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel.
        Mov Disord. 2005; 20: 832-842
        • Santamaria J.
        How to evaluate excessive daytime sleepiness in Parkinson's disease.
        Neurology. 2004; 63: S21-S23
        • Johns M.W.
        A new method for measuring daytime sleepiness: the Epworth sleepiness scale.
        Sleep. 1991; 14: 540-545
        • Arand D.
        • Bonnet M.
        • Hurwitz T.
        • et al.
        The clinical use of the MSLT and MWT.
        Sleep. 2005; 28: 123-144
        • Marinus J.
        • Visser M.
        • van Hilten J.J.
        • et al.
        Assessment of sleep and sleepiness in Parkinson disease.
        Sleep. 2003; 26: 1049-1054
        • Rye D.B.
        • Bliwise D.L.
        • Dihenia B.
        • et al.
        FAST TRACK. Daytime sleepiness in Parkinson's disease.
        J Sleep Res. 2000; 9: 63-69
        • Arnulf I.
        • Bonnet A.M.
        • Damier P.
        • et al.
        Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.
        Neurology. 2000; 55: 281-288
        • Arnulf I.
        • Konofal E.
        • Merino-Andreu M.
        • et al.
        Parkinson's disease and sleepiness: an integral part of PD.
        Neurology. 2002; 58: 1019-1024
        • Roth T.
        • Rye D.B.
        • Borcher L.D.
        • et al.
        Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists.
        Sleep Med. 2003; 4: 275-280
        • Kaynak D.
        • Kiziltan G.
        • Kaynak H.
        • et al.
        Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
        Eur J Neurol. 2005; 12: 199-207
        • Chervin R.D.
        • Aldrich M.S.
        The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea.
        Neurology. 1999; 52: 125-131
        • Razmy A.
        • Lang A.E.
        • Shapiro C.M.
        Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
        Arch Neurol. 2004; 61: 97-102
        • Stevens S.
        • Comella C.L.
        • Stepanski E.J.
        Daytime sleepiness and alertness in patients with Parkinson disease.
        Sleep. 2004; 27: 967-972
        • Rye D.B.
        • Johnston L.H.
        • Watts R.L.
        • et al.
        Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset.
        Neurology. 1999; 53: 1868-1870
        • Daley J.
        • Turner R.
        • Bliwise D.
        • et al.
        Nocturnal sleep and daytime alertness in the MPTP-treated primate.
        Sleep. 1999; 22: S218-S219
        • Hauser R.A.
        • Gauger L.
        • McDowell-Anderson W.
        • et al.
        Pramipexole-induced somnolence and episodes of daytime sleep.
        Mov Disord. 2000; 15: 658-663
        • Montastruc J.L.
        • Brefel-Courbon C.
        • Senard J.M.
        • et al.
        Sleep attacks and antiparkinsonian drugs: a pilot prospective pharamacoepidemiologic study.
        Clin Neurol. 2001; 24: 181-183
        • Pal S.
        • Bhattacharya K.F.
        • Agapito C.
        • et al.
        A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
        J Neural Transm. 2001; 108: 71-77
        • Möller J.C.
        • Stiasny K.
        • Hargutt V.
        • et al.
        Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
        Mov Disord. 2002; 17: 474-481
        • Homann C.N.
        • Wenzel K.
        • Suppan K.
        • et al.
        Sleep attacks in patients taking dopamine agonists: review.
        BMJ. 2002; 324: 1483-1487
        • Paus S.
        • Brecht H.M.
        • Köster J.
        • et al.
        Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
        Mov Disord. 2003; 18: 659-667
        • Körner Y.
        • Meindorfner C.
        • Möller J.C.
        • et al.
        Predictors of sudden onset of sleep in Parkinson's disease.
        Mov Disord. 2004; 19: 1298-1305
        • Manni R.
        • Terzaghi M.
        • Sartori I.
        • et al.
        Dopamine agonist and sleepiness in PD: review of the literature and personal findings.
        Sleep Med. 2004; 5: 189-193
        • Avorn J.
        • Scneeweiss S.
        • Sudarsky L.R.
        • et al.
        Sudden uncontrollable somnolence and medication use in Parkinson disease.
        Arch Neurol. 2005; 62: 1242-1248
        • Schapira A.H.V.
        Sleep attacks (sleep episodes) with pergolide.
        Lancet. 2000; 355: 1332-1333
        • Ferreira J.J.
        • Galitzky M.
        • Montastruc J.L.
        • et al.
        Sleep attacks and Parkinson's disease treatment.
        Lancet. 2000; 355: 1333-1334
        • Merino-Andreu M.
        • Arnulf I.
        • Konofal E.
        • et al.
        Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness.
        Neurology. 2003; 60: 1553-1554
        • Schlesinger I.
        • Ravin P.D.
        Dopamine agonists induce episodes of irresistible daytime sleepiness.
        Eur Neurol. 2003; 49: 30-33
        • Garcia-Borreguero D.
        • Schwarz C.
        • Larrosa O.
        • et al.
        L-DOPA-induce excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.
        Neurology. 2003; 61: 1008-1010
        • Homann C.N.
        • Homann B.
        • Ott E.
        • et al.
        Sleep attacks may not be a side-effect dopaminergic medication.
        Mov Disord. 2003; 18: 1569-1571
        • Ferreira J.J.
        • Thalamas C.
        • Montastruc J.L.
        • et al.
        Levodopa monotherapy can induce “sleep attacks” in Parkinson's disease patients.
        J Neurol. 2001; 248: 426-427
        • Jimenez-Jimenez F.J.
        • Velasco I.
        • Toledo M.
        • et al.
        Multiple latency test in a patient with episodes of sleep induced by pergolide.
        Rev Neurol (Barc). 2002; 34: 1140-1141
        • Bares M.
        • Kanovsky P.
        • Rektor I.
        Excessive daytime sleepiness and “sleep attacks” induced by entacapone.
        Fundam Clin Pharmacol. 2003; 17: 113-116
        • Santens P.
        Sleep attacks in Parkinson's disease induced by entacapone, a COMT-inhibitor.
        Fundam Clin Pharmacol. 2003; 17: 121-123
        • Tracik F.
        • Ebersbach G.
        Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings.
        Mov Disord. 2001; 16: 500-506
        • Ebersbach G.
        • Norden J.
        • Tracik F.
        Sleep attacks in Parkinson's disease: polysomnographic recordings.
        Mov Disord. 2000; 15: 89
        • Schäfer D.
        • Greulich W.
        Effects of parkinsonian medication on sleep.
        J Neurol. 2000; 247: 24-27
        • Romigi A.
        • Brusa L.
        • Marciani M.G.
        • et al.
        Sleep episodes and daytime somnolence as a result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
        J Neurol Sci. 2005; 228: 7-10
        • Ulivelli M.
        • Rossi S.
        • Lombardi C.
        • et al.
        Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.
        Neurology. 2002; 58: 462-465
        • Rye D.B.
        • Jankovic J.
        Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD.
        Neurology. 2002; 58: 341-346
        • Rye D.B.
        The two faces of Eve: dopamine's modulation of wakefulness and sleep.
        Neurology. 2004; 63: S2-S7
        • Ondo W.G.
        • Dat Vuong K.
        • Khan H.
        • et al.
        Daytime sleepiness and other sleep disorders in Parkinson's disease.
        Neurology. 2001; 57: 1392-1396
        • Frauscher B.
        • Höghl B.
        • Maret S.
        • et al.
        Association of daytime sleepiness with COMT polymorphism in patients with Parkinson disease: a pilot study.
        Sleep. 2004; 27: 733-736
        • Happe S.
        • Berguer K.
        • on behalf of the FAQT study investigators
        The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease: a prospective study.
        J Neurol. 2001; 248: 1062-1067
        • Gjerstad M.D.
        • Aarsland D.
        • Larsen J.P.
        Development of daytime somnolence over time in Parkinson's disease.
        Neurology. 2002; 58: 1544-1546
        • Fabbrini G.
        • Barbanti P.
        • Aurilia C.
        • et al.
        Excessive daytime somnolence in Parkinson's disease: follow-up after 1 year of treatment.
        Neurol Sci. 2003; 24: 178-179
        • Freeman A.
        • Ciliax B.
        • Bakay R.
        • et al.
        Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models.
        Ann Neurol. 2001; 50: 321-329
        • Jellinger K.A.
        Post mortem studies in Parkinson's disease: is it possible to detect brain areas for specific symptoms?.
        J Neural Transm Suppl. 1999; 56: 1-29
        • Overeem S.
        • van Hilten J.J.
        • Ripley B.
        • et al.
        Normal hypocretin-1 levels in Parkinson's disease with excessive daytime sleepiness.
        Neurology. 2002; 58: 498-499
        • Baumann C.
        • Ferini-Strambi L.
        • Waldvogel D.
        • et al.
        Parkinsonism with excessive daytime sleepiness: a narcolepsy-like disorder?.
        J Neurol. 2005; 252: 139-145
        • Drouot X.
        • Moutereau S.
        • Nguyen J.P.
        • et al.
        Low levels of ventricular CSF orexin/hypocretin in advanced PD.
        Neurology. 2003; 61: 540-543
        • Vincken W.G.
        • Gauthier S.G.
        • Dollfuss R.E.
        • et al.
        Involvement of upper-airway muscles in extrapyramidal disorders.
        N Engl J Med. 1984; 311: 438-442
        • Braga-Neto P.
        • Pereira da Sila-Junior F.
        • Sueli Monte F.
        • et al.
        Snoring and excessive daytime sleepiness in Parkinson's disease.
        J Neurol Sci. 2004; 217: 41-45
        • Martin S.E.
        • Mathur R.
        • Marshall I.
        • et al.
        The effect of age, sex, obesity and posture on upper airway size.
        Eur Respir J. 1997; 10: 2087-2090
        • Anconi-Israel S.
        • Kripke D.F.
        • Klauber M.R.
        • et al.
        Sleep-disordered breathing in community-dwelling elderly.
        Sleep. 1991; 14: 486-495
        • Bittinger L.J.
        • McNear K.K.
        • Khan F.
        • et al.
        Obstructive sleep apnea on polysomnography in patients with parkinsonism.
        Sleep. 2005; 28: A283
        • Hitchcock S.E.
        • Greer S.A.
        • Pour Ansari F.
        • et al.
        Sleep disordered breathing (SDB) in Parkinsons disease (PD).
        Sleep. 2005; 28: A286-A287
        • Diederich N.J.
        • Vaillant M.
        • Leischen M.
        • et al.
        Sleep apnea syndrome in Parkinson's disease: a case-control study in 49 patients.
        Mov Disord. 2005; 11: 1413-1418
        • Contin M.
        • Provini F.
        • Martinelli P.
        • et al.
        Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoring.
        Clin Neuropharmacol. 2003; 26: 115-118
        • Paus S.
        • Seeger G.
        • Brecht H.M.
        • et al.
        Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
        Mov Disord. 2004; 19: 705-707
        • Rissling I.
        • Geller F.
        • Bandmann O.
        • et al.
        Dopamine gene receptor gene polymorphisms in Parkinson's disease patients reporting sleep attacks.
        Mov Disord. 2004; 19: 1279-1284
        • Rissling I.
        • Köner Y.
        • Geller F.
        • et al.
        Prehypocretin polymorphysms in Parkinson disease patients reporting sleep attacks.
        Sleep. 2005; 28: 871-875
        • Barone P.
        • Amboni M.
        • Vitale C.
        • et al.
        Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease.
        Neurology. 2004; 63: S35-S38
        • Del Dotto P.
        • Gambaccini G.
        • Caneparo D.
        • et al.
        Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
        Neurol Sci. 2003; 24: 170-171
        • Hauser R.A.
        • Wahba M.N.
        • Zesiewicz T.A.
        • et al.
        Modafinil treatment of pramipexole-associated somnolence.
        Mov Disord. 2000; 15: 1269-1271
        • Högl B.
        • Saletu M.
        • Brandauer E.
        • et al.
        Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
        Sleep. 2002; 25: 905-909
        • Adler C.H.
        • Caviness J.N.
        • Hentz J.G.
        • et al.
        Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.
        Mov Disord. 2003; 18: 287-293
        • Nieves A.V.
        • Lang A.E.
        Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.
        Clin Neuropharmacol. 2002; 25: 111-114